Rigetti stock soars 7% on Friday: what's behind the bullish momentum

Rigetti stock surged 7% in pre-market trading, reaching a 52-week high of $35.81, driven by significant contract wins totaling $11.5 million. These include $5.7 million in orders for its Novera quantum systems and a $5.8 million contract with the U.S. Air Force Research Laboratory, signaling increasing commercial and defense sector validation for its quantum computing technology. The developments have fueled analyst optimism, with B. Riley raising its price target to $35, and indicate growing market confidence in Rigetti's commercialization trajectory and the broader quantum sector.

Analysis

Rigetti's stock (RGTI) has demonstrated significant bullish momentum, surging 7% in pre-market trading to reach a 52-week high of $35.81, driven by soaring trading volumes exceeding 145 million shares. This rally is underpinned by fundamental developments, specifically $11.5 million in new contract wins that signal both commercial and government validation. The company secured $5.7 million for two Novera 9-qubit quantum systems, destined for an Asian tech manufacturer and a US-based AI startup, with delivery scheduled for the first half of 2026. Concurrently, a three-year, $5.8 million contract with the U.S. Air Force Research Laboratory validates its technical expertise in the strategic area of quantum networking. These deals are material as they transition Rigetti from a research-focused entity to a commercial enterprise with paying customers and strategic government backing. The company's financial position is robust, following a $350 million equity offering in June, providing ample capital for R&D. While analyst sentiment is positive, with B. Riley setting a $35 price target, a notable divergence exists with the more conservative average target of $19.71, suggesting potential debate on current valuation.

Key Decisions for Investors

• Investors should weigh the strong positive momentum and recent contract wins against the valuation, as the stock is trading near one analyst's target of $35 but significantly above the consensus average of $19.71.
• Monitor the company's execution on its commercial and government contracts, as the delivery timeline for the Novera systems extends to 2026, making future progress reports critical validation points.
• Given the capital-intensive nature of the sector, scrutinize Rigetti's cash burn rate relative to its recent $350 million capital raise and its ability to secure further non-dilutive funding from government contracts.
• While Rigetti's success is providing a lift to peers like D-Wave and IonQ, investors should treat this as a signal of growing interest in the quantum sector rather than a direct read-through for competitors' individual prospects.